Clinical Trial Update: Safety and Efficacy of Autologous Adipose-Derived Regenerative Cells (ADRCs) Injection for Improving Diminished Ovarian Reserve [NA]

View source ↗

Summary

Clinical trial evaluating safety and efficacy of autologous adipose-derived regenerative cells (ADRCs) injections to improve diminished ovarian reserve; status …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diminished Ovarian Reserve
• Ovarian Insufficiency
• Premature Ovarian Failure

Drugs mentioned

• Autologous Adipose-Derived Regenerative Cells (ADRCs) injection (adipose-derived regenerative cells)

Snippet

Sponsor: Cytori Therapeutics | Conditions: Diminished Ovarian Reserve (DOR), Primary Ovarian Insufficiency (Poi) | NA | Status: NOT_YET_RECRUITING